Sunday, April 11, 2021

ASTERDM | Stock Price Analysis and Outlook

 

Aster DM Healthcare Ltd Ltd.


Aster DM Healthcare Limited, a healthcare conglomerate, operates hospitals, diagnostic centers, medical centers, and pharmacies in the Middle East and India. It offers primary, secondary, and tertiary healthcare with management and consultancy services. The company provides services in areas, such as cardiology, dental, dermatology, dietetics, endocrinology and diabetology, ENT, gastroenterology, general medicine, general surgery, gynaecology, neurology, ophthalmology, orthopedics, pediatrics, psychiatry, pulmonology, and urology


Key  Summary


Growth in Net Profit with increasing Profit Margin (QoQ)

Increasing profits every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Company with Zero Promoter Pledge

FII / FPI or Institutions increasing their shareholding


Technical Chart & Price Outlook



Long position in the stock can be made for the potential level of 154 /168 in short to mid term time period .


Recent Valuation Summary


Promoters holding remains unchanged at 37.88% in Dec 2020 qtr

Mutual Funds have increased holdings from 6.09% to 6.28% in Dec 2020 qtr.

Number of MF schemes increased from 6 to 7 in Dec 2020 qtr.

FII/FPI have increased holdings from 10.54% to 10.92% in Dec 2020 qtr.

Number of FII/FPI investors increased from 52 to 75 in Dec 2020 qtr.

Institutional Investors have increased holdings from 19.08% to 19.41% in Dec 2020 qtr.




Thanks for your Precious Time.


Finvest Online
Telegram  :  t.me/finvestonline






Disclaime
r- The information on this blog are based on my personal opinion and experience, it should not be considered professional financial investment advice and in no way it should be considered as a tip. We does not take any compensation of any kind whatsoever from any reader,user and company that are mention on this website.We are not SEBI registered financial advisor or analyst.


No comments:

Post a Comment